Indefinite Delivery Contract SPE2DR25D9105

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award, indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of Department of Defense (DoD) healthcare facilities worldwide. The $4,999,999 IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) worth up to $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide. The IDC, which has a period of performance through December 31, 2036, enables the DLA to issue...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, which has a performance period through December 2036,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, which has a period of performance through December 2036, enables...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The $4,999,999 IDC, valid through December 2036, covers a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications,...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical supply needs of military health facilities worldwide. The IDC, which runs through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $4,999,999 single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities and veterans' medical centers nationwide. The IDC, valid through December 2036, enables DLA to...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and other federal government agencies. The contract, valued at up to $4,999,999.00, covers a wide portfolio of branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of the Department of Defense (DoD) and other federal government agencies.

The IDC, which runs through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which aims to establish multiple regional prime vendor contracts to ensure a resilient and diversified pharmaceutical supply chain for DoD and other federal customers. The original solicitation was an unrestricted, fully competitive acquisition with a total estimated value of $30.3 billion over the base and option periods.

Generated 6/6/25, 10:11 AM